Veterinary Medicines

ANALGIN BIOPHARM 50% solution for injection

Authorised
  • Metamizole sodium monohydrate
Download as PDF

Product identification

Medicine name:
АНАЛГИН БИОФАРМ 50% инжекционен разтвор
ANALGIN BIOPHARM 50% solution for injection
Active substance:
  • Metamizole sodium monohydrate
Target species:
  • Horse
  • Cattle
  • Pig
  • Dog
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Metamizole sodium monohydrate
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        17
        day
    • Cattle
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        17
        day
    • Dog
  • Intramuscular use
    • Horse
      • Meat and offal
        17
        day
    • Cattle
      • Meat and offal
        28
        day
    • Pig
      • Meat and offal
        17
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biopharm-Engineering AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biopharm-Engineering AD
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-3064
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 11/01/2022
Download
How useful was this page?:
Average: 5 (1 vote)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."